Founded in 2014, this specialty clinic at Children's Hospital studies and treats a rare childhood genetic disorder.
Alternating hemiplegia of childhood (AHC) typically develops before 18 months of age. It causes a host of problems including sporadic paralysis, seizures, debilitating muscle contractions, abnormal eye movement, difficulty walking and developmental delays. The gene that causes AHC was only recently determined, so we expect more children will be diagnosed as awareness of the disease grows.
Our team has years of experience caring for children and adolescents with AHC. In addition to clinical care, we have robust research programs in AHC. This combination of clinical and research excellence will ensure that the best and most up to date care will be provided.
Kevin C. Ess, M.D., Ph.D. directed the establishment of our AHC clinic. Dr. Ess is the Chief of Pediatric Neurology at Vanderbilt, an accomplished physician-scientist, and specializes in the treatment of pediatric epilepsy. His research interests focus on neurogenetic disorders, including AHC and tuberous sclerosis complex.
We offer a full range of tests, treatments, and services including: